Inici › Malaltia cardiovascular › Minnesota › Minneapolis
Assaigs clínics de Malaltia cardiovascular a Minneapolis, MN
15 estudis de Malaltia cardiovascular busquen participants en centres de Minneapolis i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
ELEVATE-HFpEF Clinical Study
Reclutant
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Reclutant
- Minneapolis Heart Institute, Minneapolis
Product Surveillance Registry
ReclutantEstudi observacional
- Minneapolis, Minneapolis
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Reclutant
- Abbott Northwestern Hospital, Minneapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Reclutant
- Abbott Northwestern Hospital, Minneapolis
- University of Minnesota, Minneapolis
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
ReclutantEstudi observacional
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
ReclutantFase 3
- Research Site, Minneapolis
- Research Site, Minneapolis
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
ReclutantFase 3
- University of Minnesota, Minneapolis
- Methodist Hospital, Saint Louis Park · a 5 mi
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Reclutant
- Minneapolis Heart Institute Foundation, Minneapolis
The TRICURE EFS Study
Reclutant
- Minneapolis Heart Institute Foundation, Minneapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Reclutant
- University of Minnesota, Minneapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Reclutant
- Minneapolis Heart Institute, Minneapolis
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
ReclutantFase 3
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
ReclutantFase 1 inicial
- University of Minnesota, Minneapolis
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Reclutant
- Minneapolis Heart Institute Foundation, Minneapolis
Assaigs de Malaltia cardiovascular en altres ciutats
- Boston, MA37 estudis
- New York City, NY33 estudis
- Washington, DC29 estudis
- Houston, TX24 estudis
- Dallas, TX23 estudis
- Atlanta, GA22 estudis
- Cleveland, OH22 estudis
- Chicago, IL21 estudis
- Philadelphia, PA21 estudis
- Pittsburgh, PA20 estudis
- St. Louis, MO20 estudis
- San Francisco, CA18 estudis
Altres estudis a Minneapolis
- Càncer de mama27 estudis
- Càncer de pulmó de cèl·lules no petites26 estudis
- Càncer d'ovari24 estudis
- Càncer de pròstata23 estudis
- Càncer (tots els tipus)22 estudis
- Insuficiència cardíaca21 estudis
- Càncer de pulmó20 estudis
- Leucèmia mieloide aguda20 estudis
- Càncer colorrectal19 estudis
- Càncer d'endometri18 estudis
- Malaltia de Parkinson17 estudis
- Malaltia coronària13 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.